“These clusters could be dedicated to the development of advanced manufacturing, electric vehicles, telecom- 5G security standards, healthcare, etc. It is necessary to identify a few hotspots in the country where academic research, talent, and start-ups can co-exist and create a holistic model to build India’s innovation capacity. Israel has achieved this, and Canada is trying to emulate the model too,” said K S Viswanathan, vice-president (industry initiatives) at Nasscom.
Of the top-2,000 ER&D spenders in the world, about 48 per cent don’t have presence in India and are primarily from North America, Korea, Europe, and Japan.
Viswanathan added that the industry was working with the central and state governments to attract more such companies to come to India.
Of the 500-600 companies present in the Indian ER&D space, 45-50 per cent are engineering service providers, and 55-60 per cent are global multinational corporations (MNCs) and global contact centres.
According to Nasscom’s Strategic Review for FY22, companies such as Accenture, DXC Technology and Capgemini moved into the ER&D segment last year, while players like Cyient, Onward Technologies, VLSI/Chip design firms and medical devices firms shifted focus to greater ER&D.
“Engineering products have a direct impact on customers,” said Karthikeyan Natarajan, chief operating officer and executive director at Cyient.
According to Nasscom, India’s share in the global ER&D market is expected to grow at a compound annual growth rate (CAGR) of 12-13 per cent to reach $63 billion by 2025 from $31 billion in 2019.
This growth is being driven by global enterprises across automotive, aerospace, consumer electronics, medical devices, industrial and energy, semi-conductor, and telecom sectors.
The pandemic resulted in a global dip in ER&D spending. The ER&D global sourcing market in 2020 was $89 billion, 6 per cent less than 2019, primarily due to insourcing and carve-outs.
However, with European firms becoming more accepting of the global sourcing model, Indian service providers have begun seeing increasing traction for ER&D deals.
Natarajan said the first four to six weeks of the lockdown were challenging for ER&D projects because of plant access restrictions and lab infrastructure, but the industry bounced back.
“It was challenging for the first few weeks but the teams recovered brilliantly. Wherever there was a plant interface or testing and validation requirements, projects suffered for a while. But the advantage now is that global teams have confidence in India’s ability to work remotely. We have the unique opportunity to scale our talent pool and bring in structural changes to positively influence more projects to be centred in India,” he added.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)